Dr. Mark Smythe Net Worth

Insiders trading at Protagonist Therapeutics Inc

Over the last 8 years, insiders at Protagonist Therapeutics Inc have traded over $7,946,674 worth of Protagonist Therapeutics Inc stock and bought 3,007,840 units worth $35,519,073 . The most active insiders traders include Capital Partners Gp, L.L.C...., & Johnson Johnson & Johnson..., and X L.P.Canaan Partners X Llc.... On average, Protagonist Therapeutics Inc executives and independent directors trade stock every 39 days with the average trade being worth of $1,864,604. The most recent stock trade was executed by Suneel Gupta on 9 January 2024, trading 5,000 units of PTGX stock currently worth $36,900.